BioNTech says it will start cancer vaccine trials in the UK from September
[ad_1]
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.
[ad_2]
Source link
[ad_1]
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.
[ad_2]
Source link